MONTREAL, Jan. 17 - Canadian molecular diagnostic company Pro-DNA Diagnostic has agreed to lease its laboratory to Hemax Genome, which will use the facility to bolster its project to map the X chromosome, the firms said on Thursday.
"This agreement represents an ideal opportunity for Hemax since it gives us quick access to the infrastructures and resources we need to ensure the fast expansion of our various R&D mapping programs,'' Marc Lussier, vice-president of HemaX, said in a statement.
Meanwhile, Lambert Busque, Pro-DNA's medical and scientific director, said his firm is reserving the right to use Hemax' technology in the future to help it develop its own gene-mapping expertise.
Financial details of the agreement were not disclosed.
Pro-DNA, founded in 1995 by a group of haematologists and researchers at a Montreal hospital, published the first Canadian studies on the genetic markers of the region's French-Canadian population in 1997.
Hemax specializes in identifying genes located on the human X chromosome. The company is currently engaged in the discovery and therapeutic applications of biological factors that regulate hematopoiesis in stem cells.